Lipopolysaccharide	O
induction	O
of	O
the	O
tumor	B-DNA
necrosis	I-DNA
factor-alpha	I-DNA
promoter	I-DNA
in	O
human	B-cell_type
monocytic	I-cell_type
cells	I-cell_type
.	O

Regulation	O
by	O
Egr-1	B-protein
,	O
c-Jun	B-protein
,	O
and	O
NF-kappaB	B-protein
transcription	B-protein
factors	I-protein
.	O

Biosynthesis	O
of	O
tumor	B-protein
necrosis	I-protein
factor-alpha	I-protein
(	O
TNF-alpha	B-protein
)	O
is	O
predominantly	O
by	O
cells	O
of	O
the	O
monocytic	B-cell_type
lineage	I-cell_type
.	O

This	O
study	O
examined	O
the	O
role	O
of	O
various	O
cis-acting	B-DNA
regulatory	I-DNA
elements	I-DNA
in	O
the	O
lipopolysaccharide	O
(	O
LPS	O
)	O
induction	O
of	O
the	O
human	B-DNA
TNF-alpha	I-DNA
promoter	I-DNA
in	O
cells	O
of	O
monocytic	B-cell_type
lineage	I-cell_type
.	O

Functional	O
analysis	O
of	O
monocytic	B-cell_line
THP-1	I-cell_line
cells	I-cell_line
transfected	O
with	O
plasmids	B-DNA
containing	O
various	O
lengths	O
of	O
TNF-alpha	B-DNA
promoter	I-DNA
localized	O
enhancer	B-DNA
elements	I-DNA
in	O
a	O
region	O
(	O
-182	B-DNA
to	I-DNA
-37	I-DNA
base	I-DNA
pairs	I-DNA
(	O
bp	O
)	O
)	O
that	O
were	O
required	O
for	O
optimal	O
transcription	O
of	O
the	O
TNF-alpha	B-DNA
gene	I-DNA
in	O
response	O
to	O
LPS	O
.	O

Two	O
regions	O
were	O
identified	O
:	O
region	B-DNA
I	I-DNA
(	O
-182	B-DNA
to	I-DNA
-162	I-DNA
bp	I-DNA
)	O
contained	O
an	O
overlapping	O
Sp1/Egr-1	B-DNA
site	I-DNA
,	O
and	O
region	B-DNA
II	I-DNA
(	O
-119	B-DNA
to	I-DNA
-88	I-DNA
)	O
contained	O
CRE	B-DNA
and	O
NF-kappaB	B-DNA
(	I-DNA
designated	I-DNA
kappaB3	I-DNA
)	I-DNA
sites	I-DNA
.	O

In	O
unstimulated	O
THP-1	B-cell_line
,	O
CRE-binding	B-protein
protein	I-protein
and	O
,	O
to	O
a	O
lesser	O
extent	O
,	O
c-Jun	B-protein
complexes	I-protein
were	O
found	O
to	O
bind	O
to	O
the	O
CRE	B-DNA
site	I-DNA
.	O

LPS	O
stimulation	O
increased	O
the	O
binding	O
of	O
c-Jun-containing	B-protein
complexes	I-protein
.	O

In	O
addition	O
,	O
LPS	O
stimulation	O
induced	O
the	O
binding	O
of	O
cognate	O
nuclear	B-protein
factors	I-protein
to	O
the	O
Egr-1	B-DNA
and	I-DNA
kappaB3	I-DNA
sites	I-DNA
,	O
which	O
were	O
identified	O
as	O
Egr-1	B-protein
and	O
p50/p65	B-protein
,	O
respectively	O
.	O

The	O
CRE	B-DNA
and	I-DNA
kappaB3	I-DNA
sites	I-DNA
in	O
region	B-DNA
II	I-DNA
together	O
conferred	O
strong	O
LPS	O
responsiveness	O
to	O
a	O
heterologous	B-DNA
promoter	I-DNA
,	O
whereas	O
individually	O
they	O
failed	O
to	O
provide	O
transcriptional	O
activation	O
.	O

Furthermore	O
,	O
increasing	O
the	O
spacing	O
between	O
the	O
CRE	B-DNA
and	I-DNA
the	I-DNA
kappaB3	I-DNA
sites	I-DNA
completely	O
abolished	O
LPS	O
induction	O
,	O
suggesting	O
a	O
cooperative	O
interaction	O
between	O
c-Jun	B-protein
complexes	I-protein
and	O
p50/p65	B-protein
.	O

These	O
studies	O
indicate	O
that	O
maximal	O
LPS	O
induction	O
of	O
the	O
TNF-alpha	B-DNA
promoter	I-DNA
is	O
mediated	O
by	O
concerted	O
participation	O
of	O
at	O
least	O
two	O
separate	O
cis-acting	B-DNA
regulatory	I-DNA
elements	I-DNA
.	O

THE	NULL
JOURNAL	NULL
or	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
©	NULL
1997	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

272	NULL
,	NULL
No	NULL
.	NULL

28	NULL
,	NULL
Issue	NULL
of	NULL
July	NULL
11	NULL
,	NULL
pp	NULL
.	NULL

17795-17801	NULL
,	NULL
1997	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
Lipopolysaccharide	NULL
Induction	NULL
of	NULL
the	NULL
Tumor	NULL
Necrosis	NULL
Factor-a	NULL
«	NULL
Promoter	NULL
in	NULL
Human	NULL
Monocytic	NULL
Cells	NULL
REGULATION	NULL
BY	NULL
Egr-1	NULL
,	NULL
c-Jun	NULL
,	NULL
AND	NULL
NF-	NULL
«	NULL
B	NULL
TRANSCRIPTION	NULL
FACTORS*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
January	NULL
22	NULL
,	NULL
1997	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
May	NULL
7	NULL
,	NULL
1997	NULL
)	NULL
Jin	NULL
Yao	NULL
,	NULL
Nigel	NULL
Mackman	NULL
,	NULL
Thomas	NULL
S.	NULL
Edgington	NULL
,	NULL
and	NULL
Sao-Tah	NULL
Fant	NULL
From	NULL
the	NULL
Department	NULL
of	NULL
Immunology	NULL
,	NULL
The	NULL
Scripps	NULL
Research	NULL
Institute	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
California	NULL
92037	NULL
Biosynthesis	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor-a	NULL
(	NULL
LNF-a	NULL
)	NULL
is	NULL
predominantly	NULL
by	NULL
cells	NULL
of	NULL
the	NULL
monocytic	NULL
lineage	NULL
.	NULL

This	NULL
study	NULL
examined	NULL
the	NULL
role	NULL
of	NULL
various	NULL
cis-acting	NULL
regulatory	NULL
elements	NULL
in	NULL
the	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
induction	NULL
of	NULL
the	NULL
human	NULL
TNF-a	NULL
promoter	NULL
in	NULL
cells	NULL
of	NULL
monocytic	NULL
lineage	NULL
.	NULL

Functional	NULL
analysis	NULL
of	NULL
monocytic	NULL
THP-1	NULL
cells	NULL
transfected	NULL
with	NULL
plasmids	NULL
containing	NULL
various	NULL
lengths	NULL
of	NULL
TNF-a	NULL
promoter	NULL
localized	NULL
enhancer	NULL
elements	NULL
in	NULL
a	NULL
region	NULL
(	NULL
-182	NULL
to	NULL
-37	NULL
base	NULL
pairs	NULL
(	NULL
bp	NULL
)	NULL
)	NULL
that	NULL
were	NULL
required	NULL
for	NULL
optimal	NULL
transcription	NULL
of	NULL
the	NULL
TNF-a	NULL
gene	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
.	NULL

Two	NULL
regions	NULL
were	NULL
identified	NULL
:	NULL
region	NULL
I	NULL
(	NULL
-182	NULL
to	NULL
-162	NULL
bp	NULL
)	NULL
contained	NULL
an	NULL
overlapping	NULL
Spl/Egr-1	NULL
site	NULL
,	NULL
and	NULL
region	NULL
II	NULL
(	NULL
-119	NULL
to	NULL
-88	NULL
)	NULL
contained	NULL
CRE	NULL
and	NULL
NF-B	NULL
(	NULL
designated	NULL
B3	NULL
)	NULL
sites	NULL
.	NULL

In	NULL
unstimulated	NULL
THP	NULL
CRE-binding	NULL
protein	NULL
and	NULL
,	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
,	NULL
c-Jun	NULL
complexes	NULL
were	NULL
found	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
CRE	NULL
site	NULL
.	NULL

LPS	NULL
stimulation	NULL
increased	NULL
the	NULL
binding	NULL
of	NULL
c-Jun-containing	NULL
complexes	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
LPS	NULL
stimulation	NULL
induced	NULL
the	NULL
binding	NULL
of	NULL
cognate	NULL
nuclear	NULL
factors	NULL
to	NULL
the	NULL
Egr-1	NULL
and	NULL
«	NULL
B3	NULL
sites	NULL
,	NULL
which	NULL
were	NULL
identified	NULL
as	NULL
Egr-1	NULL
and	NULL
p50/p65	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
CRE	NULL
and	NULL
«	NULL
B3	NULL
sites	NULL
in	NULL
region	NULL
II	NULL
together	NULL
conferred	NULL
strong	NULL
LPS	NULL
responsiveness	NULL
to	NULL
a	NULL
heterologous	NULL
promoter	NULL
,	NULL
whereas	NULL
individually	NULL
they	NULL
failed	NULL
to	NULL
provide	NULL
transcriptional	NULL
activation	NULL
.	NULL

Furthermore	NULL
,	NULL
increasing	NULL
the	NULL
spacing	NULL
between	NULL
the	NULL
CRE	NULL
and	NULL
the	NULL
«	NULL
B3	NULL
sites	NULL
completely	NULL
abolished	NULL
LPS	NULL
induction	NULL
,	NULL
suggesting	NULL
a	NULL
cooperative	NULL
interaction	NULL
between	NULL
c-Jun	NULL
complexes	NULL
and	NULL
p50/p65	NULL
.	NULL

These	NULL
studies	NULL
indicate	NULL
that	NULL
maximal	NULL
LPS	NULL
induction	NULL
of	NULL
the	NULL
TNF-a	NULL
«	NULL
promoter	NULL
is	NULL
mediated	NULL
by	NULL
concerted	NULL
participation	NULL
of	NULL
at	NULL
least	NULL
two	NULL
separate	NULL
cis-acting	NULL
regulatory	NULL
elements	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
produced	NULL
primarily	NULL
by	NULL
cells	NULL
of	NULL
monocytic	NULL
lineage	NULL
,	NULL
is	NULL
involved	NULL
in	NULL
a	NULL
plethora	NULL
of	NULL
cell	NULL
regulatory	NULL
and	NULL
differentiative	NULL
processes	NULL
.	NULL

TNF-a	NULL
is	NULL
also	NULL
a	NULL
vital	NULL
mediator	NULL
of	NULL
the	NULL
host	NULL
defense	NULL
against	NULL
infection	NULL
and	NULL
tumor	NULL
formation	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
TNF-a	NULL
@	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
pathophysiology	NULL
of	NULL
numerous	NULL
diseases	NULL
including	NULL
septic	NULL
shock	NULL
,	NULL
cachexia	NULL
,	NULL
and	NULL
various	NULL
autoimmune	NULL
diseases	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
TNF-a	NULL
exhibits	NULL
both	NULL
beneficial	NULL
and	NULL
pathologic	NULL
effects	NULL
,	NULL
a	NULL
feature	NULL
that	NULL
requires	NULL
rigorous	NULL
control	NULL
of	NULL
its	NULL
expression	NULL
.	NULL

Regulation	NULL
of	NULL
human	NULL
TNF-a	NULL
expres-	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grants	NULL
HL-16411	NULL
and	NULL
HL-48872.The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1784	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

{	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Dept	NULL
.	NULL

of	NULL
Immunology	NULL
,	NULL
IMM	NULL
17	NULL
,	NULL
The	NULL
Scripps	NULL
Research	NULL
Institute	NULL
,	NULL
10550	NULL
N.	NULL
Torrey	NULL
Pines	NULL
Rd	NULL
.	NULL

,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
92037	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
619-784-8226	NULL
;	NULL
Fax	NULL
:	NULL
619-784-8480	NULL
;	NULL
E-mail	NULL
:	NULL
stfan	NULL
@	NULL
scripps.edu	NULL
.	NULL

*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
TNF-	NULL
@	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor-a	NULL
;	NULL
LPS	NULL
,	NULL
lipopolysaccharide	NULL
;	NULL
bp	NULL
,	NULL
base	NULL
pair	NULL
(	NULL
s	NULL
)	NULL
;	NULL
PMA	NULL
,	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
CRE	NULL
,	NULL
cAMP-re-sponsive	NULL
element	NULL
;	NULL
CREB	NULL
,	NULL
CRE-binding	NULL
protein	NULL
.	NULL

This	NULL
paper	NULL
is	NULL
available	NULL
on	NULL
line	NULL
at	NULL
http	NULL
:	NULL
//www.jbc.org	NULL
sion	NULL
in	NULL
cells	NULL
of	NULL
monocytic	NULL
lineage	NULL
is	NULL
quite	NULL
complex	NULL
,	NULL
involving	NULL
controls	NULL
at	NULL
both	NULL
transcriptional	NULL
and	NULL
post-transcriptional	NULL
levels	NULL
(	NULL
2	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
both	NULL
5	NULL
and	NULL
3	NULL
'	NULL
nucleotide	NULL
sequences	NULL
influence	NULL
LPS-induced	NULL
transcription	NULL
of	NULL
human	NULL
TNF-a	NULL
cDNA	NULL
transfected	NULL
into	NULL
the	NULL
murine	NULL
macrophage	NULL
RAW264.7	NULL
cell	NULL
line	NULL
(	NULL
8	NULL
)	NULL
.	NULL

The	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
human	NULL
TNF-a	NULL
gene	NULL
contains	NULL
a	NULL
complex	NULL
array	NULL
of	NULL
potential	NULL
regulatory	NULL
elements	NULL
.	NULL

In	NULL
T	NULL
cells	NULL
,	NULL
cooperation	NULL
between	NULL
the	NULL
CRE	NULL
and	NULL
the	NULL
adjacent	NULL
«	NULL
B3	NULL
sites	NULL
is	NULL
required	NULL
for	NULL
calcium-mediated	NULL
TNF-a	NULL
promoter	NULL
activity	NULL
(	NULL
4	NULL
)	NULL
,	NULL
and	NULL
cooperation	NULL
between	NULL
the	NULL
CRE	NULL
and	NULL
the	NULL
adjacent	NULL
Ets	NULL
sites	NULL
for	NULL
PMA-induced	NULL
activity	NULL
(	NULL
5	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
role	NULL
or	NULL
these	NULL
regulatory	NULL
elements	NULL
in	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
TNF-a	NULL
gene	NULL
in	NULL
human	NULL
monocytes	NULL
remains	NULL
unclear	NULL
.	NULL

To	NULL
date	NULL
,	NULL
published	NULL
reports	NULL
indicate	NULL
that	NULL
activation	NULL
of	NULL
TNF-	NULL
«	NULL
gene	NULL
transcription	NULL
in	NULL
human	NULL
monocytes	NULL
in	NULL
response	NULL
to	NULL
various	NULL
stimuli	NULL
is	NULL
mediated	NULL
by	NULL
a	NULL
region	NULL
within	NULL
-200	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
transcriptional	NULL
start	NULL
site	NULL
(	NULL
6-12	NULL
)	NULL
.	NULL

Using	NULL
a	NULL
promonocytic	NULL
leukemia	NULL
cell	NULL
line	NULL
,	NULL
U937	NULL
,	NULL
several	NULL
nuclear	NULL
factor	NULL
binding	NULL
elements	NULL
,	NULL
including	NULL
AP-1	NULL
(	NULL
6	NULL
)	NULL
,	NULL
Egr-1	NULL
(	NULL
7	NULL
)	NULL
,	NULL
CRE	NULL
(	NULL
8	NULL
)	NULL
,	NULL
C/EBPB	NULL
(	NULL
9	NULL
)	NULL
,	NULL
and	NULL
AP-2	NULL
(	NULL
10	NULL
)	NULL
,	NULL
have	NULL
been	NULL
suggested	NULL
to	NULL
mediate	NULL
TNF-a	NULL
«	NULL
transcription	NULL
in	NULL
response	NULL
to	NULL
PMA	NULL
or	NULL
cytokines	NULL
.	NULL

These	NULL
results	NULL
appear	NULL
to	NULL
be	NULL
incomplete	NULL
and	NULL
often	NULL
conflicting	NULL
.	NULL

No	NULL
consensus	NULL
has	NULL
been	NULL
reached	NULL
,	NULL
and	NULL
no	NULL
cooperation	NULL
between	NULL
these	NULL
regulatory	NULL
elements	NULL
was	NULL
established	NULL
.	NULL

Although	NULL
the	NULL
reasons	NULL
for	NULL
these	NULL
discrepancies	NULL
are	NULL
unclear	NULL
,	NULL
the	NULL
U937	NULL
cell	NULL
line	NULL
may	NULL
be	NULL
too	NULL
poorly	NULL
differentiated	NULL
to	NULL
serve	NULL
as	NULL
a	NULL
suitable	NULL
model	NULL
of	NULL
gene	NULL
expression	NULL
in	NULL
cells	NULL
of	NULL
monocytic	NULL
lineage	NULL
.	NULL

Transcriptional	NULL
activation	NULL
of	NULL
the	NULL
murine	NULL
TNF-	NULL
«	NULL
gene	NULL
in	NULL
murine	NULL
macrophages	NULL
has	NULL
been	NULL
demonstrated	NULL
to	NULL
be	NULL
predominantly	NULL
dependent	NULL
on	NULL
a	NULL
region	NULL
in	NULL
the	NULL
murine	NULL
TNF-a	NULL
promoter	NULL
upstream	NULL
of	NULL
-451	NULL
bp	NULL
,	NULL
which	NULL
contains	NULL
NF-	NULL
«	NULL
B	NULL
DNA	NULL
binding	NULL
motifs	NULL
(	NULL
13	NULL
,	NULL
14	NULL
)	NULL
.	NULL

A	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II	NULL
Y	NULL
box	NULL
was	NULL
also	NULL
inferred	NULL
to	NULL
play	NULL
a	NULL
role	NULL
in	NULL
LPS	NULL
inducibility	NULL
(	NULL
13	NULL
,	NULL
14	NULL
)	NULL
.	NULL

To	NULL
date	NULL
,	NULL
the	NULL
role	NULL
of	NULL
NF-KB	NULL
in	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
human	NULL
TNF-a	NULL
gene	NULL
in	NULL
human	NULL
monocytes	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
is	NULL
contro-versial	NULL
.	NULL

An	NULL
early	NULL
study	NULL
using	NULL
murine	NULL
monocytic	NULL
cells	NULL
failed	NULL
to	NULL
identify	NULL
a	NULL
role	NULL
for	NULL
the	NULL
«	NULL
B	NULL
sites	NULL
in	NULL
transcriptional	NULL
activation	NULL
of	NULL
human	NULL
TNF-a	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
or	NULL
virus	NULL
(	NULL
15	NULL
)	NULL
.	NULL

However	NULL
,	NULL
recent	NULL
reports	NULL
employing	NULL
pharmacological	NULL
agents	NULL
that	NULL
block	NULL
the	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
such	NULL
as	NULL
pyrrolidine	NULL
dithio-carbamate	NULL
(	NULL
16	NULL
)	NULL
,	NULL
and	NULL
sodium	NULL
salicylate	NULL
(	NULL
17	NULL
)	NULL
,	NULL
demonstrated	NULL
a	NULL
suppression	NULL
of	NULL
TNF-a	NULL
gene	NULL
expression	NULL
.	NULL

Moreover	NULL
,	NULL
LPS	NULL
induction	NULL
of	NULL
the	NULL
human	NULL
TNF-a	NULL
promoter	NULL
in	NULL
human	NULL
monocytic	NULL
THP-1	NULL
leukemia	NULL
cells	NULL
was	NULL
mediated	NULL
by	NULL
the	NULL
«	NULL
B3	NULL
site	NULL
at	NULL
-97	NULL
bp	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
a	NULL
likelihood	NULL
that	NULL
murine	NULL
monocytic	NULL
cells	NULL
are	NULL
not	NULL
suitable	NULL
for	NULL
the	NULL
analysis	NULL
of	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
human	NULL
TNF-a	NULL
promoter	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
employed	NULL
a	NULL
line	NULL
of	NULL
THP-1	NULL
cells	NULL
that	NULL
exhibits	NULL
high	NULL
inducibility	NULL
for	NULL
TNF-a	NULL
gene	NULL
transcription	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
freshly	NULL
isolated	NULL
human	NULL
monocytes	NULL
.	NULL

We	NULL
have	NULL
performed	NULL
a	NULL
comprehensive	NULL
analysis	NULL
of	NULL
the	NULL
role	NULL
of	NULL
various	NULL
cis-acting	NULL
regulatory	NULL
elements	NULL
in	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
17795	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
17796	NULL
116	NULL
106	NULL
-97	NULL
Ets	NULL
CRE	NULL
kB3	NULL
587	NULL
21200	NULL
172	NULL
sd	NULL
42	NULL
AP-1	NULL
Spt	NULL
AP2	NULL
Lue	NULL
I	NULL
i	NULL
|	NULL
T	NULL
«	NULL
B1	NULL
xB2	NULL
Spf/egm1	NULL
1	NULL
1	NULL
1	NULL
I	NULL
LPS	NULL
Induction	NULL
of	NULL
TNF-a	NULL
Promoter	NULL
in	NULL
Human	NULL
Monocytes	NULL
36	NULL
Fold	NULL
Induction	NULL
608	NULL
10	NULL
12	NULL
14	NULL
16	NULL
16	NULL
ames	NULL
|	NULL
DTNF	NULL
(	NULL
1311	NULL
)	NULL
Luc	NULL
A311	NULL
ame	NULL
|	NULL
DTNF	NULL
(	NULL
1185	NULL
)	NULL
Luc	NULL
sm	NULL
|	NULL
DTNF	NULL
(	NULL
615	NULL
)	NULL
Luc	NULL
1135	NULL
-+	NULL
2	NULL
«	NULL
615	NULL
+	NULL
479	NULL
7	NULL
,	NULL
295	NULL
/	NULL
amma	NULL
-	NULL
DTNF	NULL
(	NULL
479	NULL
)	NULL
LUC	NULL
-	NULL
pTNF	NULL
(	NULL
295	NULL
)	NULL
Luc	NULL
182.	NULL
.	NULL

pTNF	NULL
(	NULL
-182	NULL
)	NULL
Luc	NULL
~164	NULL
-	NULL
k-	NULL
--	NULL
-	NULL
--	NULL
r	NULL
-	NULL
(	NULL
161	NULL
)	NULL
Luc	NULL
A20	NULL
.	NULL

pTNF	NULL
(	NULL
120	NULL
)	NULL
Luc	NULL
95	NULL
.	NULL

pTNF	NULL
(	NULL
95	NULL
)	NULL
Luc	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

LPS	NULL
induction	NULL
of	NULL
the	NULL
TNF-a	NULL
promoter	NULL
from	NULL
a	NULL
5	NULL
'	NULL
deletion	NULL
series	NULL
.	NULL

The	NULL
5	NULL
'	NULL
boundaries	NULL
of	NULL
plasmids	NULL
containing	NULL
various	NULL
truncations	NULL
of	NULL
236	NULL
-am	NULL
PTNF	NULL
(	NULL
36	NULL
)	NULL
Luc	NULL
the	NULL
TNF-a	NULL
promoter	NULL
are	NULL
shown	NULL
.	NULL

The	NULL
average	NULL
fold	NULL
induction	NULL
of	NULL
luciferase	NULL
activity	NULL
expressed	NULL
by	NULL
each	NULL
plasmid	NULL
in	NULL
transiently	NULL
transfected	NULL
THP-1	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
is	NULL
shown	NULL
with	NULL
S.D	NULL
.	NULL

Results	NULL
of	NULL
a	NULL
representative	NULL
experiment	NULL
are	NULL
shown	NULL
.	NULL

The	NULL
basal	NULL
luciferase	NULL
activity	NULL
(	NULL
light	NULL
units	NULL
)	NULL
levels	NULL
per	NULL
10°	NULL
cells	NULL
are	NULL
as	NULL
follows	NULL
:	NULL
pTNF	NULL
(	NULL
131l1	NULL
)	NULL
Luc	NULL
,	NULL
18,546	NULL
;	NULL
pTNF	NULL
(	NULL
-1135	NULL
)	NULL
Luc	NULL
,	NULL
12,606	NULL
;	NULL
pTNF	NULL
(	NULL
-615	NULL
)	NULL
Lue	NULL
,	NULL
19,319	NULL
;	NULL
pTNF	NULL
(	NULL
-479	NULL
)	NULL
Lue	NULL
,	NULL
12,311	NULL
;	NULL
pTNF	NULL
(	NULL
-295	NULL
)	NULL
Lue	NULL
,	NULL
17,636	NULL
;	NULL
pTNF	NULL
(	NULL
-182	NULL
)	NULL
Luc	NULL
,	NULL
18,288	NULL
;	NULL
pTNF	NULL
(	NULL
-161	NULL
)	NULL
Lue	NULL
,	NULL
13,833	NULL
;	NULL
pTNF	NULL
(	NULL
-120	NULL
)	NULL
Lue	NULL
,	NULL
11,818	NULL
;	NULL
pTNF	NULL
(	NULL
-95	NULL
)	NULL
Liue	NULL
,	NULL
9457	NULL
;	NULL
pTNF	NULL
(	NULL
-86	NULL
)	NULL
Luc	NULL
,	NULL
1659	NULL
;	NULL
the	NULL
background	NULL
is	NULL
425	NULL
light	NULL
units	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
observed	NULL
in	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

Region	NULL
I	NULL
Region	NULL
I1	NULL
M-	NULL
ft	NULL
--	NULL
-I	NULL
~182	NULL
~162	NULL
120	NULL
B8	NULL
O	NULL
{	NULL
-O	NULL
Egr-1	NULL
CRE	NULL
«	NULL
B3	NULL
APA	NULL
AP2	NULL
Fold	NULL
Induction	NULL
2	NULL
4	NULL
6	NULL
8040	NULL
42	NULL
14	NULL
16	NULL
18	NULL
Luc	NULL
eis	NULL
1/2	NULL
E0	NULL
in	NULL
,	NULL
+74	NULL
x	NULL
--	NULL
-OG-O	NULL
--	NULL
O-O-®	NULL
©Pewy	NULL
17	NULL
%	NULL
KPa	NULL
h/	NULL
{	NULL
]	NULL
{	NULL
]	NULL
-x	NULL
{	NULL
_|	NULL
{	NULL
--	NULL
L	NULL
}	NULL
)	NULL
-®==	NULL
AP	NULL
ring	NULL
17/	NULL
{	NULL
-	NULL
C-O	NULL
x	NULL
PP	NULL
ang	NULL
I-77	NULL
OG	NULL
--	NULL
C-O	NULL
--	NULL
O	NULL
x-mas	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

LPS	NULL
induction	NULL
of	NULL
TNF-a	NULL
promoter	NULL
from	NULL
mutant	NULL
series	NULL
.	NULL

The	NULL
position	NULL
of	NULL
mutations	NULL
in	NULL
corresponding	NULL
regulatory	NULL
motifs	NULL
are	NULL
marked	NULL
.	NULL

Oligonucleotides	NULL
used	NULL
for	NULL
producing	NULL
these	NULL
plasmids	NULL
are	NULL
listed	NULL
in	NULL
Table	NULL
I	NULL
.	NULL

The	NULL
«	NULL
B3	NULL
mutant	NULL
was	NULL
generated	NULL
using	NULL
the	NULL
«	NULL
B3	NULL
m2	NULL
oligonucleotide	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Fold	NULL
induction	NULL
of	NULL
luciferase	NULL
activity	NULL
expressed	NULL
by	NULL
each	NULL
plasmid	NULL
in	NULL
transiently	NULL
transfected	NULL
THP-1	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
of	NULL
duplicate	NULL
samples	NULL
with	NULL
S.D	NULL
.	NULL

are	NULL
shown	NULL
.	NULL

Results	NULL
are	NULL
representative	NULL
of	NULL
four	NULL
independent	NULL
experiments	NULL
.	NULL

the	NULL
human	NULL
TNF-	NULL
«	NULL
gene	NULL
.	NULL

Using	NULL
LPS	NULL
stimulation	NULL
as	NULL
a	NULL
paradigm	NULL
,	NULL
we	NULL
find	NULL
that	NULL
a	NULL
mechanism	NULL
involving	NULL
several	NULL
transcription	NULL
factors	NULL
is	NULL
required	NULL
for	NULL
maximal	NULL
TNF-a	NULL
promoter	NULL
activity	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Cell	NULL
and	NULL
Reagents	NULL
THP-1	NULL
monocytic	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
medium	NULL
RPMI	NULL
1640	NULL
with	NULL
8	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

Human	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
were	NULL
isolated	NULL
by	NULL
gradient	NULL
centrifugation	NULL
as	NULL
described	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Antibodies	NULL
used	NULL
in	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
:	NULL
anti-Eigr-1	NULL
,	NULL
anti-CREB	NULL
,	NULL
anti-ATF-2	NULL
,	NULL
anti-c-Jun	NULL
,	NULL
anti-JunB	NULL
,	NULL
anti-JunD	NULL
,	NULL
anti-c-Fos	NULL
,	NULL
anti-Fos	NULL
B	NULL
,	NULL
anti-p50	NULL
,	NULL
anti-p65	NULL
,	NULL
anti-c-Rel	NULL
,	NULL
and	NULL
anti-Ets1/2	NULL
were	NULL
form	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
(	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Plasmids	NULL
5	NULL
-Deletion	NULL
Series-pTNF	NULL
(	NULL
-1811	NULL
)	NULL
Lue	NULL
,	NULL
pTNF	NULL
(	NULL
-1185	NULL
)	NULL
Luc	NULL
,	NULL
pTNF	NULL
(	NULL
-615	NULL
)	NULL
Lue	NULL
,	NULL
pTNF	NULL
(	NULL
-479	NULL
)	NULL
Lue	NULL
,	NULL
pTNF	NULL
(	NULL
-295	NULL
)	NULL
Lue	NULL
,	NULL
pTNF	NULL
(	NULL
-120	NULL
)	NULL
Lue	NULL
,	NULL
pTNF	NULL
(	NULL
-95	NULL
)	NULL
Luc	NULL
,	NULL
and	NULL
pTNF	NULL
(	NULL
-86	NULL
)	NULL
Luc	NULL
(	NULL
19	NULL
)	NULL
were	NULL
generously	NULL
provided	NULL
by	NULL
Dr.	NULL
J.	NULL
Economou	NULL
(	NULL
UCLA	NULL
,	NULL
Los	NULL
Angeles	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

pTNF	NULL
(	NULL
-182	NULL
)	NULL
Lue	NULL
and	NULL
pTNF	NULL
(	NULL
-161	NULL
)	NULL
Luc	NULL
were	NULL
produced	NULL
by	NULL
cloning	NULL
polymerase	NULL
chain	NULL
reaction	NULL
fragments	NULL
containing	NULL
sequences	NULL
of	NULL
-182	NULL
to	NULL
+15	NULL
or	NULL
-161	NULL
to	NULL
+15	NULL
,	NULL
respectively	NULL
,	NULL
into	NULL
the	NULL
Smal	NULL
site	NULL
of	NULL
the	NULL
pXP1	NULL
expression	NULL
vector	NULL
.	NULL

Mutant	NULL
Series-Plasmids	NULL
containing	NULL
site-specific	NULL
mutations	NULL
at	NULL
AP-1	NULL
,	NULL
AP-2	NULL
,	NULL
or	NULL
CRE	NULL
sites	NULL
(	NULL
6	NULL
)	NULL
were	NULL
provided	NULL
by	NULL
Dr.	NULL
J.	NULL
Economou	NULL
.	NULL

Additional	NULL
mutant	NULL
plasmids	NULL
in	NULL
this	NULL
series	NULL
were	NULL
produced	NULL
according	NULL
to	NULL
methods	NULL
described	NULL
in	NULL
the	NULL
Transformer	NULL
site-directed	NULL
mutagenesis	NULL
kit	NULL
(	NULL
CLONTECH	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
the	NULL
oligonucleotides	NULL
with	NULL
site-specific	NULL
mutations	NULL
used	NULL
for	NULL
these	NULL
constructs	NULL
are	NULL
listed	NULL
in	NULL
Table	NULL
I.	NULL
Heterologous	NULL
Promoter	NULL
Series-Multiple	NULL
copies	NULL
of	NULL
oligonucleotides	NULL
containing	NULL
sequences	NULL
from	NULL
the	NULL
human	NULL
TNF-	NULL
@	NULL
promoter	NULL
were	NULL
cloned	NULL
upstream	NULL
of	NULL
the	NULL
minimal	NULL
SV40	NULL
promoter	NULL
driving	NULL
expression	NULL
of	NULL
the	NULL
luciferase	NULL
reporter	NULL
gene	NULL
in	NULL
pGL2-promoter	NULL
(	NULL
Promega	NULL
Corp.	NULL
)	NULL
.	NULL

Sequences	NULL
of	NULL
oligonucleotides	NULL
used	NULL
for	NULL
producing	NULL
these	NULL
constructs	NULL
are	NULL
listed	NULL
in	NULL
Table	NULL
I	NULL
.	NULL

All	NULL
plasmids	NULL
were	NULL
verified	NULL
by	NULL
DNA	NULL
sequencing	NULL
.	NULL

610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
LPS	NULL
Induction	NULL
of	NULL
TNF-a	NULL
Promoter	NULL
in	NULL
Human	NULL
Monocytes	NULL
SV40-Luc	NULL
10	NULL
100	NULL
pGL2	NULL
-mm	NULL
5	NULL
Co	NULL
*	NULL
*	NULL
ee	NULL
-	NULL
lng	NULL
103	NULL
-86	NULL
(	NULL
CRE	NULL
)	NULL
,	NULL
|	NULL
HBH	NULL
-	NULL
>	NULL
2k	NULL
>	NULL
>	NULL
>	NULL
-In	NULL
=	NULL
~112	NULL
92	NULL
CRE	NULL
xB3	NULL
(	NULL
1107-86	NULL
)	NULL
,	NULL
-	NULL
Fe	NULL
-	NULL
0	NULL
nll	NULL
l_	NULL
--	NULL
name	NULL
f	NULL
I	NULL
I	NULL
I	NULL
I	NULL
B	NULL
4	NULL
8	NULL
12	NULL
16	NULL
CRE	NULL
«	NULL
B3	NULL
(	NULL
1106-86	NULL
)	NULL
,	NULL
-	NULL
Fea	NULL
-s	NULL
2020222	NULL
on-	NULL
-ne	NULL
r-B3	NULL
(	NULL
11086m1	NULL
)	NULL
,	NULL
-	NULL
xe	NULL
Wix	NULL
mac	NULL
222222222	NULL
eee	NULL
}	NULL
-	NULL
CRE	NULL
(	NULL
1107-862	NULL
)	NULL
,	NULL
-	NULL
+	NULL
>	NULL
+	NULL
>	NULL
>	NULL
>	NULL
>	NULL
>	NULL
>	NULL
>	NULL
>	NULL
>	NULL
>	NULL
--	NULL
lnt	NULL
[	NULL
-o	NULL
C	NULL
to	NULL
&	NULL
(	NULL
1107-86	NULL
)	NULL
,	NULL
TC	NULL
n	NULL
BC-	NULL
-	NULL
0+	NULL
00+	NULL
>	NULL
>	NULL
>	NULL
H	NULL
‘	NULL
5/	NULL
+5	NULL
+5	NULL
(	NULL
110-8645	NULL
)	NULL
,	NULL
“	NULL
MM	NULL
--	NULL
--	NULL
--	NULL
--	NULL
-	NULL
-ing	NULL
5	NULL
<	NULL
o/	NULL
+10	NULL
,	NULL
10	NULL
(	NULL
Moreer10	NULL
)	NULL
,	NULL
“	NULL
SAM	NULL
--	NULL
--	NULL
--	NULL
--	NULL
-	NULL
-ing	NULL
5	NULL
<	NULL
7	NULL
+15	NULL
+15	NULL
rug-44544544—	NULL
--	NULL
--	NULL
--	NULL
--	NULL
-	NULL
-am	NULL
17797	NULL
Fold	NULL
_	NULL
Induction	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Induction	NULL
of	NULL
the	NULL
TNF-a	NULL
promoter	NULL
from	NULL
heterologous	NULL
promoter	NULL
series	NULL
by	NULL
LPS	NULL
.	NULL

Plasmids	NULL
of	NULL
this	NULL
series	NULL
contain	NULL
the	NULL
minimal	NULL
SV40	NULL
promoter	NULL
upstream	NULL
of	NULL
luciferase	NULL
gene	NULL
in	NULL
pGL2-promoter	NULL
vector	NULL
.	NULL

A	NULL
,	NULL
multiple	NULL
tandem	NULL
copies	NULL
of	NULL
DNA	NULL
fragments	NULL
containing	NULL
sequences	NULL
of	NULL
interest	NULL
are	NULL
cloned	NULL
upstream	NULL
of	NULL
the	NULL
SV40	NULL
minimal	NULL
promoter	NULL
.	NULL

B	NULL
,	NULL
two	NULL
tandem	NULL
copies	NULL
of	NULL
DNA	NULL
fragments	NULL
(	NULL
-110	NULL
to	NULL
-86	NULL
)	NULL
containing	NULL
both	NULL
the	NULL
CRE	NULL
and	NULL
the	NULL
«	NULL
B	NULL
sites	NULL
,	NULL
or	NULL
DNA	NULL
fragments	NULL
containing	NULL
bp	NULL
substitutions	NULL
in	NULL
either	NULL
site	NULL
(	NULL
marked	NULL
with	NULL
x	NULL
)	NULL
are	NULL
cloned	NULL
upstream	NULL
of	NULL
the	NULL
SV40	NULL
minimal	NULL
promoter	NULL
.	NULL

C	NULL
,	NULL
three	NULL
tandem	NULL
copies	NULL
of	NULL
DNA	NULL
fragments	NULL
(	NULL
-110	NULL
to	NULL
-86	NULL
)	NULL
with	NULL
wild	NULL
type	NULL
sequence	NULL
or	NULL
with	NULL
5	NULL
,	NULL
10	NULL
,	NULL
or	NULL
15	NULL
extra	NULL
bases	NULL
inserted	NULL
between	NULL
the	NULL
CRE	NULL
and	NULL
the	NULL
«	NULL
B3	NULL
sites	NULL
were	NULL
cloned	NULL
upstream	NULL
of	NULL
SV40	NULL
minimal	NULL
promoter	NULL
.	NULL

The	NULL
average	NULL
fold	NULL
induction	NULL
of	NULL
luciferase	NULL
activity	NULL
expressed	NULL
by	NULL
each	NULL
plasmids	NULL
in	NULL
transiently	NULL
transfected	NULL
THP-1	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
is	NULL
shown	NULL
.	NULL

Results	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

DNA	NULL
Transfection	NULL
A	NULL
DEAE-dextran	NULL
transfection	NULL
procedure	NULL
(	NULL
18	NULL
,	NULL
20	NULL
)	NULL
was	NULL
used	NULL
.	NULL

Briefly	NULL
,	NULL
3	NULL
X	NULL
10	NULL
``	NULL
THP-1	NULL
cells	NULL
were	NULL
resuspended	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
Tris-buffered	NULL
saline	NULL
and	NULL
incubated	NULL
for	NULL
10	NULL
to	NULL
20	NULL
min	NULL
at	NULL
37	NULL
°C	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
plasmid	NULL
DNA	NULL
and	NULL
80	NULL
ug	NULL
of	NULL
DEAE-dextran	NULL
(	NULL
Pharmacia	NULL
,	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
.	NULL

During	NULL
incu-bation	NULL
,	NULL
cells	NULL
were	NULL
monitored	NULL
closely	NULL
for	NULL
permeability	NULL
to	NULL
trypan	NULL
blue	NULL
.	NULL

Transfection	NULL
was	NULL
stopped	NULL
by	NULL
adding	NULL
large	NULL
volumes	NULL
of	NULL
Tris-buffered	NULL
saline	NULL
,	NULL
usually	NULL
after	NULL
10	NULL
min	NULL
,	NULL
when	NULL
20-30	NULL
%	NULL
of	NULL
cells	NULL
are	NULL
permeable	NULL
to	NULL
trypan	NULL
blue	NULL
.	NULL

After	NULL
washing	NULL
with	NULL
Tris-buffered	NULL
saline	NULL
,	NULL
cells	NULL
were	NULL
cultivated	NULL
in	NULL
media	NULL
for	NULL
48	NULL
h.	NULL
Cells	NULL
were	NULL
stimulated	NULL
with	NULL
5	NULL
pg/ml	NULL
LPS	NULL
(	NULL
Escherichia	NULL
coli	NULL
0111	NULL
:	NULL
B4	NULL
purchased	NULL
from	NULL
Calbiochem	NULL
,	NULL
Lia	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
in	NULL
a	NULL
96-well	NULL
plate	NULL
at	NULL
1	NULL
X	NULL
10°	NULL
cells/well	NULL
.	NULL

After	NULL
7	NULL
h	NULL
of	NULL
incubation	NULL
at	NULL
37	NULL
°C	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
luciferase	NULL
activity	NULL
was	NULL
determined	NULL
using	NULL
an	NULL
assay	NULL
kit	NULL
(	NULL
Promega	NULL
)	NULL
and	NULL
the	NULL
Monolight	NULL
2010	NULL
luminometer	NULL
(	NULL
Analytical	NULL
Luminescence	NULL
Laboratory	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Nuclear	NULL
Extracts	NULL
and	NULL
EMSA	NULL
Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
5	NULL
X	NULL
10°	NULL
THP-1	NULL
cells	NULL
or	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
stimulated	NULL
under	NULL
various	NULL
conditions	NULL
as	NULL
described	NULL
(	NULL
18	NULL
,	NULL
20	NULL
)	NULL
.	NULL

Protein	NULL
concentrations	NULL
in	NULL
nuclear	NULL
extracts	NULL
were	NULL
determined	NULL
by	NULL
BCA	NULL
protein	NULL
assay	NULL
(	NULL
Pierce	NULL
)	NULL
.	NULL

Oligonucleotide	NULL
probes	NULL
were	NULL
radiolabeled	NULL
using	NULL
[	NULL
a-*	NULL
``	NULL
PIdCTP	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
(	NULL
1-5	NULL
ug	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
radiolabeled	NULL
oligonucleotide	NULL
probes	NULL
(	NULL
0.2-1	NULL
X	NULL
10°	NULL
cpm	NULL
)	NULL
in	NULL
2	NULL
X	NULL
binding	NULL
buffer	NULL
(	NULL
100	NULL
mM	NULL
KCl	NULL
,	NULL
1	NULL
my	NULL
EDTA	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
2	NULL
mM	NULL
dithio-threitol	NULL
,	NULL
2	NULL
mg/ml	NULL
bovine	NULL
serum	NULL
albumin	NULL
,	NULL
0.2	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
and	NULL
40	NULL
mM	NULL
Hepes	NULL
)	NULL
for	NULL
20	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Samples	NULL
were	NULL
subjected	NULL
to	NULL
electrophoresis	NULL
through	NULL
6	NULL
%	NULL
non-denaturing	NULL
acrylamide	NULL
gels	NULL
(	NULL
Novex	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
in	NULL
0.5	NULL
x	NULL
Tris	NULL
borate-EDTA	NULL
buffer	NULL
.	NULL

For	NULL
antibody	NULL
supershift	NULL
experiments	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
preincubated	NULL
20	NULL
min	NULL
with	NULL
2	NULL
ug	NULL
of	NULL
antibody	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
labeled	NULL
probe	NULL
.	NULL

RESULTS	NULL
Localization	NULL
of	NULL
DNA	NULL
Elements	NULL
Involved	NULL
in	NULL
the	NULL
Transcriptional	NULL
Activation	NULL
of	NULL
the	NULL
TNF-a	NULL
Gene	NULL
in	NULL
Response	NULL
to	NULL
LPS-To	NULL
define	NULL
the	NULL
5	NULL
boundary	NULL
of	NULL
LPS	NULL
responsive	NULL
elements	NULL
,	NULL
THP-1	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
a	NULL
series	NULL
of	NULL
plasmids	NULL
containing	NULL
progressive	NULL
truncations	NULL
of	NULL
the	NULL
55	NULL
promoter	NULL
sequence	NULL
between	NULL
-1311	NULL
bp	NULL
and	NULL
-36	NULL
bp	NULL
.	NULL

Deletion	NULL
of	NULL
sequences	NULL
upstream	NULL
of	NULL
-182	NULL
had	NULL
no	NULL
significant	NULL
effect	NULL
on	NULL
LPS-induction	NULL
of	NULL
the	NULL
TNF-a	NULL
promoter	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Removal	NULL
of	NULL
a	NULL
region	NULL
from	NULL
-182	NULL
to	NULL
-162	NULL
,	NULL
which	NULL
contains	NULL
an	NULL
Spl/Egr-1	NULL
overlapping	NULL
site	NULL
,	NULL
reduced	NULL
LPS	NULL
inducibility	NULL
by	NULL
50	NULL
%	NULL
(	NULL
from	NULL
13.3-fold	NULL
to	NULL
7.8-fold	NULL
)	NULL
.	NULL

Removal	NULL
of	NULL
a	NULL
region	NULL
between	NULL
-161	NULL
and	NULL
-121	NULL
had	NULL
no	NULL
significant	NULL
effect	NULL
on	NULL
the	NULL
LPS	NULL
inducibility	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
deletion	NULL
to	NULL
-95	NULL
,	NULL
which	NULL
removes	NULL
Ets	NULL
,	NULL
CRE	NULL
,	NULL
and	NULL
«	NULL
B	NULL
(	NULL
«	NULL
B3	NULL
)	NULL
sites	NULL
,	NULL
further	NULL
reduced	NULL
LPS	NULL
inducibility	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
deletion	NULL
to	NULL
-36	NULL
removed	NULL
a	NULL
region	NULL
containing	NULL
a	NULL
Spl	NULL
site	NULL
and	NULL
abolished	NULL
basal	NULL
promoter	NULL
activity	NULL
.	NULL

These	NULL
results	NULL
provide	NULL
new	NULL
and	NULL
substantial	NULL
evidence	NULL
that	NULL
LPS	NULL
induction	NULL
of	NULL
the	NULL
TNF-a	NULL
gene	NULL
in	NULL
monocytes	NULL
involves	NULL
at	NULL
least	NULL
two	NULL
regulatory	NULL
elements	NULL
;	NULL
region	NULL
I	NULL
(	NULL
-182	NULL
to	NULL
-162	NULL
)	NULL
and	NULL
region	NULL
II	NULL
(	NULL
-120	NULL
to	NULL
-96	NULL
)	NULL
.	NULL

Determination	NULL
of	NULL
the	NULL
Roles	NULL
of	NULL
Various	NULL
Binding	NULL
Sites	NULL
in	NULL
the	NULL
Human	NULL
TNF-a	NULL
Promoter	NULL
by	NULL
Functional	NULL
Analysis	NULL
of	NULL
Mutant	NULL
Plasmids-To	NULL
determine	NULL
the	NULL
functional	NULL
role	NULL
of	NULL
nuclear	NULL
binding	NULL
motifs	NULL
in	NULL
the	NULL
region	NULL
identified	NULL
by	NULL
5'-truncation	NULL
analysis	NULL
,	NULL
plasmids	NULL
with	NULL
specific	NULL
site-directed	NULL
mutations	NULL
were	NULL
examined	NULL
.	NULL

Mutation	NULL
in	NULL
the	NULL
Egr-1	NULL
site	NULL
(	NULL
-169	NULL
bp	NULL
)	NULL
,	NULL
the	NULL
CRE	NULL
site	NULL
(	NULL
-106	NULL
bp	NULL
)	NULL
,	NULL
as	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
17798	NULL
LPS	NULL
Induction	NULL
of	NULL
TNF-a	NULL
Promoter	NULL
in	NULL
Human	NULL
Monocytes	NULL
well	NULL
as	NULL
the	NULL
«	NULL
B3	NULL
site	NULL
(	NULL
-97	NULL
bp	NULL
)	NULL
,	NULL
markedly	NULL
reduced	NULL
LPS	NULL
induction	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
AP-1	NULL
(	NULL
-57	NULL
bp	NULL
)	NULL
or	NULL
AP-2	NULL
(	NULL
-36	NULL
bp	NULL
)	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
LPS	NULL
induction	NULL
of	NULL
the	NULL
TNF-a	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

These	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
our	NULL
findings	NULL
using	NULL
the	NULL
5'-deletion	NULL
series	NULL
of	NULL
plasmids	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Functional	NULL
Analysis	NULL
of	NULL
the	NULL
CRE	NULL
and	NULL
«	NULL
kB3	NULL
Sites	NULL
in	NULL
Heterologous	NULL
Promoter	NULL
Plasmids-To	NULL
further	NULL
explore	NULL
the	NULL
potential	NULL
of	NULL
these	NULL
nuclear	NULL
factor	NULL
binding	NULL
motifs	NULL
to	NULL
function	NULL
as	NULL
enhancer	NULL
elements	NULL
,	NULL
we	NULL
examined	NULL
their	NULL
ability	NULL
to	NULL
confer	NULL
inducibility	NULL
to	NULL
heterologous	NULL
promoter	NULL
.	NULL

Neither	NULL
four	NULL
tandem	NULL
copies	NULL
of	NULL
the	NULL
B3	NULL
nor	NULL
two	NULL
copies	NULL
of	NULL
the	NULL
CRE	NULL
sites	NULL
alone	NULL
conferred	NULL
LPS	NULL
inducibility	NULL
to	NULL
a	NULL
SV40	NULL
minimal	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
.	NULL

However	NULL
,	NULL
when	NULL
two	NULL
or	NULL
three	NULL
copies	NULL
of	NULL
a	NULL
DNA	NULL
fragment	NULL
spanning	NULL
both	NULL
the	NULL
CRE	NULL
and	NULL
the	NULL
xB	NULL
sites	NULL
were	NULL
cloned	NULL
upstream	NULL
of	NULL
the	NULL
SV40	NULL
promoter	NULL
strong	NULL
LPS	NULL
inducibility	NULL
was	NULL
observed	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

Mutation	NULL
of	NULL
either	NULL
the	NULL
CRE	NULL
site	NULL
(	NULL
-110/-86	NULL
m1	NULL
)	NULL
or	NULL
the	NULL
«	NULL
B3	NULL
site	NULL
(	NULL
-110/-86	NULL
m2	NULL
)	NULL
completely	NULL
abolished	NULL
LPS	NULL
inducibility	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
LPS	NULL
induction	NULL
of	NULL
human	NULL
TNF-a	NULL
transcription	NULL
requires	NULL
cooperative	NULL
interaction	NULL
between	NULL
proteins	NULL
bound	NULL
to	NULL
the	NULL
CRE	NULL
and	NULL
«	NULL
B	NULL
sites	NULL
.	NULL

There	NULL
is	NULL
only	NULL
1	NULL
base	NULL
pair	NULL
separating	NULL
the	NULL
CRE	NULL
and	NULL
«	NULL
B3	NULL
sites	NULL
.	NULL

Whether	NULL
the	NULL
close	NULL
proximity	NULL
of	NULL
the	NULL
CRE	NULL
site	NULL
and	NULL
the	NULL
«	NULL
B3	NULL
site	NULL
is	NULL
required	NULL
for	NULL
the	NULL
optimal	NULL
transactivation	NULL
of	NULL
TNF-a	NULL
was	NULL
investigated	NULL
.	NULL

For	NULL
these	NULL
experiments	NULL
,	NULL
5	NULL
,	NULL
10	NULL
,	NULL
or	NULL
15	NULL
additional	NULL
base	NULL
pairs	NULL
were	NULL
added	NULL
between	NULL
.	NULL

CRE	NULL
and	NULL
«	NULL
B3	NULL
sites	NULL
and	NULL
oligonucleotides	NULL
were	NULL
cloned	NULL
into	NULL
pGL2-promoter	NULL
.	NULL

These	NULL
insertions	NULL
created	NULL
1/2	NULL
,	NULL
1	NULL
,	NULL
or	NULL
1	NULL
1/2	NULL
extra	NULL
turns	NULL
of	NULL
the	NULL
DNA	NULL
helix	NULL
between	NULL
these	NULL
two	NULL
sites	NULL
.	NULL

Fig	NULL
.	NULL

3C	NULL
shows	NULL
that	NULL
insertion	NULL
of	NULL
DNA	NULL
between	NULL
these	NULL
two	NULL
sites	NULL
abolished	NULL
LPS	NULL
inducibility	NULL
.	NULL

Identification	NULL
of	NULL
Transcription	NULL
Factors	NULL
That	NULL
Bind	NULL
to	NULL
the	NULL
Egr-1	NULL
,	NULL
CRE	NULL
,	NULL
and	NULL
«	NULL
B3	NULL
Sites-EMSA	NULL
were	NULL
performed	NULL
to	NULL
determine	NULL
which	NULL
transcription	NULL
factors	NULL
bind	NULL
to	NULL
sites	NULL
in	NULL
regions	NULL
I	NULL
and	NULL
II	NULL
of	NULL
the	NULL
human	NULL
TNF-a	NULL
promoter	NULL
.	NULL

Region	NULL
I	NULL
:	NULL
Egr-1	NULL
and	NULL
Sp1-An	NULL
oligonucleotide	NULL
containing	NULL
only	NULL
the	NULL
Egr-1	NULL
site	NULL
bound	NULL
an	NULL
LPS	NULL
and	NULL
phorbol	NULL
ester-inducible	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
.	NULL

This	NULL
complex	NULL
was	NULL
not	NULL
observed	NULL
when	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
mutant	NULL
Egr-l1	NULL
site	NULL
was	NULL
used	NULL
as	NULL
the	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
lanes	NULL
4-6	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
this	NULL
LPS-inducible	NULL
complex	NULL
was	NULL
supershifted	NULL
by	NULL
anti-Egr-1	NULL
antibody	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
lane	NULL
9	NULL
)	NULL
,	NULL
demonstrating	NULL
that	NULL
Egr-1	NULL
bound	NULL
to	NULL
this	NULL
site	NULL
.	NULL

A	NULL
prominent	NULL
complex	NULL
was	NULL
observed	NULL
when	NULL
nuclear	NULL
extracts	NULL
from	NULL
unstimulated	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
an	NULL
oligonucleotide	NULL
spanning	NULL
the	NULL
overlapping	NULL
Spl/Egr-1	NULL
sites	NULL
(	NULL
-182	NULL
to	NULL
-157	NULL
bp	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

This	NULL
complex	NULL
was	NULL
not	NULL
induced	NULL
by	NULL
LPS	NULL
(	NULL
Zane	NULL
2	NULL
)	NULL
but	NULL
was	NULL
supershifted	NULL
using	NULL
an	NULL
anti-Spl	NULL
antibody	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
this	NULL
complex	NULL
was	NULL
not	NULL
observed	NULL
using	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
mutated	NULL
Spl	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lanes	NULL
5-8	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
demonstrated	NULL
that	NULL
Spl	NULL
bound	NULL
to	NULL
this	NULL
site	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
constitutively	NULL
expressed	NULL
Spl	NULL
complex	NULL
,	NULL
LPS	NULL
stimulation	NULL
of	NULL
cells	NULL
resulted	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
an	NULL
Egr-1	NULL
complex	NULL
that	NULL
bound	NULL
to	NULL
the	NULL
oligonucleotide	NULL
containing	NULL
overlapping	NULL
Spl/Egr-1	NULL
sites	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
this	NULL
LPS	NULL
inducible	NULL
Egr-1	NULL
complex	NULL
was	NULL
observed	NULL
using	NULL
the	NULL
Sp1	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
/Egr-1	NULL
oligonucleotide	NULL
as	NULL
a	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

The	NULL
Egr-1	NULL
complex	NULL
A	NULL
Probe	NULL
-	NULL
Egr-1	NULL
mut	NULL
Probe	NULL
Egr-1	NULL
LPS	NULL
-	NULL
%	NULL
-	NULL
-	NULL
+	NULL
-	NULL
LPS	NULL
-	NULL
+	NULL
+	NULL
PMA	NULL
-	NULL
-	NULL
+	NULL
-	NULL
-	NULL
+0	NULL
antiégm1	NULL
-	NULL
-	NULL
+	NULL
va	NULL
»	NULL
~	NULL
a	NULL
»	NULL
fip	NULL
aa	NULL
aa	NULL
Egr-1	NULL
-	NULL
»	NULL
ius	NULL
tut	NULL
|	NULL
Egr-1	NULL
-	NULL
»	NULL
ll	NULL
:	NULL
i	NULL
a	NULL
ina	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
B	NULL
Probe	NULL
SPimu/Egr1	NULL
LPS	NULL
-	NULL
#	NULL
#	NULL
4+	NULL
-	NULL
+	NULL
+	NULL
+	NULL
anti§p1	NULL
-	NULL
-	NULL
%	NULL
-	NULL
-	NULL
-	NULL
+	NULL
antiEegm	NULL
-	NULL
-	NULL
-	NULL
4+	NULL
-	NULL
-	NULL
-	NULL
+	NULL
Sp1-	NULL
»	NULL
Egr-1	NULL
-	NULL
»	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

LPS	NULL
induction	NULL
of	NULL
Egr-1	NULL
nuclear	NULL
factor	NULL
.	NULL

A	NULL
,	NULL
nuclear	NULL
extract	NULL
from	NULL
unstimulated	NULL
THP-1	NULL
or	NULL
THP-1	NULL
stimulated	NULL
with	NULL
LPS	NULL
(	NULL
10	NULL
ug/m1	NULL
)	NULL
or	NULL
PMA	NULL
(	NULL
10	NULL
nM	NULL
)	NULL
for	NULL
1	NULL
h	NULL
were	NULL
probed	NULL
with	NULL
labeled	NULL
oligonucleotide	NULL
probes	NULL
of	NULL
either	NULL
wild	NULL
type	NULL
sequence	NULL
or	NULL
mutant	NULL
sequence	NULL
of	NULL
Egr-1	NULL
site	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

B	NULL
,	NULL
probes	NULL
used	NULL
were	NULL
oligonucleotide	NULL
spanning	NULL
overlapping	NULL
Spl/Egr-1	NULL
site	NULL
(	NULL
-182	NULL
to	NULL
-157	NULL
)	NULL
or	NULL
oligonucleotide	NULL
containing	NULL
base	NULL
substitutions	NULL
in	NULL
Spl	NULL
site	NULL
,	NULL
Spl	NULL
...	NULL
.	NULL

/Egr-1	NULL
(	NULL
-182/-157	NULL
m1	NULL
,	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

For	NULL
antibody	NULL
supershift	NULL
experiment	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
antibody	NULL
(	NULL
2	NULL
ug	NULL
)	NULL
for	NULL
20	NULL
min	NULL
before	NULL
addition	NULL
of	NULL
probes	NULL
.	NULL

TaBLE	NULL
I	NULL
Oligonucleotides	NULL
used	NULL
in	NULL
this	NULL
study	NULL
Respective	NULL
binding	NULL
sequences	NULL
are	NULL
in	NULL
bold	NULL
type	NULL
.	NULL

Base	NULL
substitutions	NULL
or	NULL
insertions	NULL
are	NULL
underlined	NULL
.	NULL

Name	NULL
Position	NULL
Sequence	NULL
(	NULL
5'-3	NULL
'	NULL
)	NULL
Egr-1	NULL
-168	NULL
to	NULL
-145	NULL
CCCCGCCCCCGCCGATGGACAAGAA	NULL
Egr-1m	NULL
-168	NULL
to	NULL
-145	NULL
CCCCGCCCCAGATATCGAGAAGAA	NULL
CRE	NULL
-112	NULL
to	NULL
-92	NULL
TCCAGATGAGCTCATGGGTITC	NULL
CREm1	NULL
-112	NULL
to	NULL
-92	NULL
TCCAGATGAGIGIATGGGITC	NULL
CREm2	NULL
-112	NULL
to	NULL
-92	NULL
TCCAGATCTCATCATGGGTITC	NULL
«	NULL
BL	NULL
-594	NULL
to	NULL
-577	NULL
AAGCCTGGGACAGCCCCG	NULL
«	NULL
B2	NULL
-217	NULL
to	NULL
-200	NULL
TGTGAGGGGTATCCTIGA	NULL
xB3	NULL
-103	NULL
to	NULL
-86	NULL
GCTCATGGGTTTCTCCAC	NULL
kB3m1l	NULL
-103	NULL
to	NULL
-86	NULL
GCTCATTTATITCTICCAC	NULL
-105	NULL
to	NULL
-82	NULL
CAGCTCATGGATATCTCCACCAAG	NULL
-182/-157	NULL
-182	NULL
to	NULL
-157	NULL
CTTCCAAATCCCCGCCCcceceaATC	NULL
-182/-157ml	NULL
-182	NULL
to	NULL
-157	NULL
CTTTCCAAATATTCGCCCCCGCGATG	NULL
-110/-86	NULL
-110	NULL
to	NULL
-86	NULL
CAGATGAGCTCATGGGTTTCTCCAC	NULL
-110/-86ml	NULL
-110	NULL
to	NULL
-86	NULL
CAGATCTCATCATGGGITTCTCCAC	NULL
-110/-86m2	NULL
-110	NULL
to	NULL
-86	NULL
CAGATGAGCTCATGAATTTCTAAAC	NULL
-110/-86+5	NULL
-110	NULL
to	NULL
-86	NULL
CAGATGAGCTCATATCGIGGGTITCTICCAC	NULL
-110/-86+10	NULL
-110	NULL
to	NULL
-86	NULL
CAGATGAGCTCATATCGTATCGIGGGTITICTCCAC	NULL
-110/-86+15	NULL
-110	NULL
to	NULL
-86	NULL
CAGATGAGCTCATATCGTATCGTATCGTGGGITTCTCCAC	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
LPS	NULL
Induction	NULL
of	NULL
TNF-a	NULL
Promoter	NULL
in	NULL
Human	NULL
Monocytes	NULL
A	NULL
B	NULL
probe	NULL
-	NULL
kB1	NULL
kB2	NULL
-	NULL
kB3	NULL
probe	NULL
|	NULL
kB1	NULL
kB2	NULL
kB3	NULL
LpS	NULL
r	NULL
ra	NULL
m	NULL
--	NULL
A	NULL
im	NULL
--	NULL
-	NULL
m	NULL
f	NULL
~	NULL
+o	NULL
-	NULL
+	NULL
LPS	NULL
-	NULL
$	NULL
-	NULL
4	NULL
%	NULL
-	NULL
+	NULL
h	NULL
T	NULL
%	NULL
3	NULL
wath	NULL
%	NULL
kB	NULL
-	NULL
»	NULL
kB	NULL
-	NULL
»	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
1	NULL
C	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
probe	NULL
kB1	NULL
kB3	NULL
ups	NULL
(	NULL
-	NULL
+	NULL
r	NULL
a	NULL
'	NULL
.	NULL

+	NULL
+	NULL
anti	NULL
p50	NULL
-	NULL
-	NULL
4	NULL
-o	NULL
-	NULL
4	NULL
anti	NULL
p6§	NULL
-	NULL
-	NULL
-	NULL
$	NULL
-	NULL
-	NULL
4	NULL
%	NULL
«	NULL
#	NULL
»	NULL
u	NULL
Lad	NULL
p50/p65	NULL
-	NULL
»	NULL
.	NULL
'	NULL

be	NULL
#	NULL
s	NULL
.	NULL

add	NULL
dik	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

LPS	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
p50/p65	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
THP-1	NULL
(	NULL
A	NULL
)	NULL
or	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
(	NULL
B	NULL
)	NULL
were	NULL
probed	NULL
with	NULL
oligonucleotide	NULL
spanning	NULL
«	NULL
B1	NULL
,	NULL
«	NULL
B2	NULL
,	NULL
or	NULL
«	NULL
B3	NULL
site	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

C	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
preincubated	NULL
with	NULL
antibodies	NULL
(	NULL
2	NULL
ug	NULL
)	NULL
for	NULL
20	NULL
min	NULL
before	NULL
adding	NULL
probes	NULL
.	NULL

was	NULL
not	NULL
affected	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
an	NULL
anti-Spl	NULL
antibody	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
7	NULL
)	NULL
,	NULL
but	NULL
was	NULL
supershifted	NULL
with	NULL
an	NULL
anti-Egr-1	NULL
antibody	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
8	NULL
)	NULL
.	NULL

Region	NULL
II	NULL
:	NULL
«	NULL
B3	NULL
and	NULL
CRE-EMSA	NULL
were	NULL
performed	NULL
with	NULL
oligonucleotides	NULL
spanning	NULL
three	NULL
putative	NULL
kB	NULL
sites	NULL
:	NULL
«	NULL
Bl	NULL
(	NULL
-594	NULL
to	NULL
-577	NULL
)	NULL
,	NULL
«	NULL
B2	NULL
(	NULL
-216	NULL
to	NULL
-199	NULL
)	NULL
,	NULL
and	NULL
«	NULL
B3	NULL
(	NULL
-104	NULL
to	NULL
-87	NULL
)	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

As	NULL
depicted	NULL
in	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
LPS	NULL
stimulation	NULL
of	NULL
cells	NULL
resulted	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
nuclear	NULL
protein-DNA	NULL
complexes	NULL
with	NULL
kB1l	NULL
(	NULL
Zane	NULL
2	NULL
)	NULL
and	NULL
«	NULL
B3	NULL
(	NULL
Zane	NULL
6	NULL
)	NULL
,	NULL
but	NULL
not	NULL
with	NULL
xB2	NULL
(	NULL
Zane	NULL
4	NULL
)	NULL
.	NULL

More	NULL
protein	NULL
bound	NULL
to	NULL
«	NULL
B1	NULL
that	NULL
B3	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
found	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
human	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

Monospecific	NULL
anti-p50	NULL
and	NULL
anti-p65	NULL
antibodies	NULL
were	NULL
used	NULL
in	NULL
supershift	NULL
experiments	NULL
to	NULL
identify	NULL
the	NULL
protein	NULL
composition	NULL
of	NULL
the	NULL
complexes	NULL
formed	NULL
with	NULL
the	NULL
«	NULL
B1	NULL
and	NULL
«	NULL
B3	NULL
sites	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5C	NULL
,	NULL
the	NULL
LPS	NULL
induced	NULL
complex	NULL
binding	NULL
either	NULL
to	NULL
the	NULL
kB1	NULL
or	NULL
to	NULL
the	NULL
«	NULL
B3	NULL
oligonucleotides	NULL
were	NULL
supershifted	NULL
by	NULL
anti-p50	NULL
and	NULL
also	NULL
by	NULL
anti-p65	NULL
antibodies	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
they	NULL
were	NULL
composed	NULL
of	NULL
p50/p65	NULL
heterodimers	NULL
.	NULL

Furthermore	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
«	NULL
B3	NULL
site	NULL
(	NULL
«	NULL
B3	NULL
m2	NULL
,	NULL
Table	NULL
I	NULL
)	NULL
abolished	NULL
binding	NULL
of	NULL
p50/p65	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Importantly	NULL
,	NULL
the	NULL
same	NULL
mutation	NULL
significantly	NULL
reduced	NULL
LPS	NULL
inducibility	NULL
of	NULL
the	NULL
TNF-a	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Using	NULL
a	NULL
prototypic	NULL
CRE	NULL
site	NULL
as	NULL
a	NULL
probe	NULL
,	NULL
we	NULL
demonstrated	NULL
that	NULL
CREB	NULL
was	NULL
constitutively	NULL
expressed	NULL
in	NULL
unstimulated	NULL
THP-1	NULL
cells	NULL
and	NULL
that	NULL
CREB	NULL
binding	NULL
was	NULL
not	NULL
induced	NULL
by	NULL
LPS	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
LPS	NULL
stimulation	NULL
increased	NULL
the	NULL
amount	NULL
of	NULL
protein	NULL
binding	NULL
to	NULL
the	NULL
non-consensus	NULL
CRE	NULL
site	NULL
from	NULL
the	NULL
TNF-a	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
compare	NULL
lanes	NULL
1	NULL
and	NULL
4	NULL
)	NULL
.	NULL

Antibody	NULL
supershift	NULL
experiments	NULL
were	NULL
performed	NULL
to	NULL
determine	NULL
the	NULL
proteins	NULL
that	NULL
bound	NULL
to	NULL
the	NULL
CRE	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

In	NULL
unstimulated	NULL
cells	NULL
,	NULL
the	NULL
17799	NULL
A	NULL
LPS—+—	NULL
;	NULL
:	NULL
w	NULL
2	NULL
Antibody	NULL
-53	NULL
m	NULL
C	NULL
probe	NULL
CRE	NULL
_	NULL
CREmu	NULL
LPS	NULL
-	NULL
-	NULL
+	NULL
++	NULL
anti	NULL
CREB	NULL
-	NULL
-	NULL
-	NULL
+	NULL
antic-Jun	NULL
-	NULL
-	NULL
-	NULL
-	NULL
+	NULL
10	NULL
2	NULL
3	NULL
4	NULL
5	NULL
B	NULL
LPS	NULL
-	NULL
-	NULL
-	NULL
%	NULL
+	NULL
+	NULL
anti	NULL
CREB	NULL
-	NULL
4	NULL
-	NULL
-	NULL
4	NULL
antio_Jun	NULL
-	NULL
-	NULL
4	NULL
-	NULL
-	NULL
+	NULL
”	NULL
‘	NULL
4	NULL
bu	NULL
)	NULL
sales	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
10	NULL
2	NULL
3	NULL
4	NULL
50	NULL
6	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

LPS	NULL
induction	NULL
of	NULL
nuclear	NULL
factors	NULL
binding	NULL
to	NULL
CRE	NULL
site	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
unstimulated	NULL
or	NULL
LPS-stimulated	NULL
THP-1	NULL
cells	NULL
were	NULL
probed	NULL
with	NULL
oligonucleotide	NULL
probe	NULL
spanning	NULL
the	NULL
prototypic	NULL
CRE	NULL
sequence	NULL
(	NULL
A	NULL
)	NULL
,	NULL
TNF-a	NULL
promoter	NULL
wild	NULL
type	NULL
CRE	NULL
sequence	NULL
(	NULL
B	NULL
)	NULL
,	NULL
or	NULL
mutant	NULL
CRE	NULL
sequence	NULL
(	NULL
CREm2	NULL
,	NULL
C	NULL
)	NULL
.	NULL

Sequences	NULL
of	NULL
these	NULL
oligonucleotides	NULL
are	NULL
shown	NULL
in	NULL
Table	NULL
I	NULL
.	NULL

For	NULL
antibody	NULL
supershift	NULL
experiments	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
various	NULL
antibodies	NULL
(	NULL
2	NULL
ug	NULL
)	NULL
for	NULL
20	NULL
min	NULL
before	NULL
adding	NULL
probes	NULL
.	NULL

majority	NULL
of	NULL
the	NULL
complex	NULL
was	NULL
supershifted	NULL
using	NULL
an	NULL
anti-CREB	NULL
antibody	NULL
,	NULL
whereas	NULL
only	NULL
a	NULL
minor	NULL
supershift	NULL
was	NULL
observed	NULL
using	NULL
an	NULL
anti-c-Jun	NULL
antibody	NULL
.	NULL

In	NULL
LPS-stimulated	NULL
cells	NULL
,	NULL
the	NULL
anti-c-Jun	NULL
antibody	NULL
supershift	NULL
the	NULL
majority	NULL
of	NULL
the	NULL
complex	NULL
,	NULL
whereas	NULL
the	NULL
anti-CREB	NULL
antibody	NULL
formed	NULL
a	NULL
minor	NULL
supershift	NULL
band	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
LPS	NULL
does	NULL
not	NULL
increase	NULL
the	NULL
binding	NULL
of	NULL
CREB	NULL
,	NULL
consistent	NULL
with	NULL
our	NULL
results	NULL
using	NULL
a	NULL
prototype	NULL
CRE	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
,	NULL
and	NULL
that	NULL
LPS	NULL
increases	NULL
binding	NULL
of	NULL
c-Jun-containing	NULL
complexes	NULL
to	NULL
the	NULL
CRE	NULL
site	NULL
from	NULL
the	NULL
TNF-	NULL
«	NULL
promoter	NULL
.	NULL

Using	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
mutated	NULL
CRE	NULL
site	NULL
(	NULL
CREm2	NULL
,	NULL
Table	NULL
I	NULL
)	NULL
,	NULL
we	NULL
observed	NULL
a	NULL
reduction	NULL
in	NULL
the	NULL
total	NULL
amount	NULL
of	NULL
protein	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
LPS	NULL
stimulation	NULL
did	NULL
not	NULL
increase	NULL
complex	NULL
formation	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
.	NULL

This	NULL
complex	NULL
was	NULL
supershifted	NULL
by	NULL
an	NULL
anti-CREB	NULL
antibody	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
but	NULL
was	NULL
not	NULL
recognized	NULL
by	NULL
an	NULL
anti-c-Jun	NULL
antibody	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
small	NULL
amounts	NULL
of	NULL
CREB	NULL
still	NULL
bound	NULL
to	NULL
the	NULL
mutated	NULL
CRE	NULL
site	NULL
.	NULL

Since	NULL
these	NULL
same	NULL
base	NULL
substitutions	NULL
completely	NULL
abolished	NULL
the	NULL
functional	NULL
activity	NULL
of	NULL
the	NULL
CRE	NULL
site	NULL
in	NULL
transfected	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
,	NULL
these	NULL
results	NULL
provide	NULL
additional	NULL
evidence	NULL
that	NULL
c-Jun-containing	NULL
complexes	NULL
,	NULL
rather	NULL
than	NULL
CREB	NULL
,	NULL
play	NULL
a	NULL
crucial	NULL
role	NULL
in	NULL
LPS	NULL
induction	NULL
of	NULL
the	NULL
TNF-a	NULL
promoter	NULL
.	NULL

DISCUSSION	NULL
In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
have	NULL
defined	NULL
two	NULL
cis-acting	NULL
regulatory	NULL
elements	NULL
in	NULL
the	NULL
human	NULL
TNF-	NULL
«	NULL
promoter	NULL
that	NULL
mediated	NULL
maximal	NULL
LPS	NULL
induction	NULL
of	NULL
TNF-a	NULL
gene	NULL
expression	NULL
in	NULL
cells	NULL
of	NULL
monocytic	NULL
lineage	NULL
.	NULL

Region	NULL
I	NULL
contained	NULL
an	NULL
overlapping	NULL
Spl/Egr-1	NULL
site	NULL
(	NULL
-182	NULL
to	NULL
-162	NULL
)	NULL
,	NULL
whereas	NULL
region	NULL
II	NULL
(	NULL
-120	NULL
to	NULL
-96	NULL
)	NULL
contained	NULL
CRE	NULL
and	NULL
«	NULL
B	NULL
sites	NULL
.	NULL

Functional	NULL
studies	NULL
demonstrated	NULL
that	NULL
Egr-1	NULL
binding	NULL
to	NULL
region	NULL
I	NULL
was	NULL
required	NULL
for	NULL
LPS	NULL
induction	NULL
of	NULL
the	NULL
TNF-a	NULL
promoter	NULL
in	NULL
monocytes	NULL
.	NULL

Egr-1	NULL
protein	NULL
expression	NULL
was	NULL
induced	NULL
by	NULL
LPS	NULL
stimulation	NULL
(	NULL
21	NULL
)	NULL
.	NULL

The	NULL
Egr-1	NULL
site	NULL
at	NULL
-169	NULL
bp	NULL
is	NULL
part	NULL
of	NULL
the	NULL
Sp1/Egr-1	NULL
overlapping	NULL
sequence	NULL
motif	NULL
.	NULL

In	NULL
unstimulated	NULL
monocytes	NULL
,	NULL
Spl	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
17800	NULL
binds	NULL
to	NULL
this	NULL
site	NULL
,	NULL
whereas	NULL
upon	NULL
LPS	NULL
stimulation	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
Egr-1	NULL
displaces	NULL
Spl	NULL
to	NULL
mediate	NULL
induction	NULL
of	NULL
TNF-a	NULL
promoter	NULL
activity	NULL
.	NULL

Previously	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
Egr-1	NULL
can	NULL
displace	NULL
Spl	NULL
from	NULL
a	NULL
similar	NULL
overlapping	NULL
Spl/Egr-1	NULL
site	NULL
(	NULL
22	NULL
)	NULL
.	NULL

The	NULL
role	NULL
of	NULL
Spl	NULL
bound	NULL
to	NULL
this	NULL
upstream	NULL
Spl	NULL
site	NULL
at	NULL
-172	NULL
is	NULL
un-known	NULL
,	NULL
although	NULL
our	NULL
results	NULL
using	NULL
a	NULL
plasmid	NULL
containing	NULL
a	NULL
mutation	NULL
in	NULL
the	NULL
Spl	NULL
site	NULL
suggest	NULL
that	NULL
it	NULL
does	NULL
not	NULL
mediate	NULL
basal	NULL
expression	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
Spl	NULL
site	NULL
at	NULL
-56	NULL
bp	NULL
dramatically	NULL
reduces	NULL
basal	NULL
expression	NULL
by	NULL
65	NULL
%	NULL
.	NULL
``	NULL

Further	NULL
functional	NULL
studies	NULL
showed	NULL
that	NULL
the	NULL
CRE	NULL
and	NULL
«	NULL
B3	NULL
sites	NULL
in	NULL
region	NULL
II	NULL
were	NULL
required	NULL
for	NULL
LPS	NULL
induction	NULL
of	NULL
the	NULL
TNF-a	NULL
promoter	NULL
.	NULL

We	NULL
demonstrated	NULL
that	NULL
«	NULL
B3	NULL
(	NULL
-97	NULL
)	NULL
bound	NULL
p50/p65	NULL
heterodimers	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
we	NULL
found	NULL
no	NULL
role	NULL
for	NULL
«	NULL
B1	NULL
(	NULL
-588	NULL
)	NULL
despite	NULL
its	NULL
ability	NULL
to	NULL
bind	NULL
p50/p65	NULL
.	NULL

A	NULL
recent	NULL
study	NULL
by	NULL
Trede	NULL
et	NULL
al	NULL
.	NULL

(	NULL
11	NULL
)	NULL
also	NULL
showed	NULL
a	NULL
role	NULL
for	NULL
«	NULL
B3	NULL
in	NULL
LPS	NULL
induction	NULL
of	NULL
the	NULL
TNF-a	NULL
promoter	NULL
in	NULL
THP-1	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
these	NULL
investigators	NULL
did	NULL
not	NULL
identify	NULL
other	NULL
regulatory	NULL
regions	NULL
,	NULL
possibly	NULL
due	NULL
to	NULL
the	NULL
low	NULL
level	NULL
of	NULL
induction	NULL
(	NULL
about	NULL
4-fold	NULL
)	NULL
of	NULL
the	NULL
TNF-	NULL
«	NULL
promoter	NULL
(	NULL
11	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
our	NULL
studies	NULL
are	NULL
in	NULL
agreement	NULL
with	NULL
an	NULL
earlier	NULL
report	NULL
(	NULL
16	NULL
)	NULL
,	NULL
showing	NULL
that	NULL
p50/p65	NULL
binds	NULL
with	NULL
much	NULL
less	NULL
avidity	NULL
to	NULL
«	NULL
B3	NULL
than	NULL
«	NULL
B1	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
protein-protein	NULL
interaction	NULL
of	NULL
p50/p65	NULL
with	NULL
c-Jun	NULL
proteins	NULL
bound	NULL
to	NULL
the	NULL
adjacent	NULL
CRE	NULL
site	NULL
is	NULL
required	NULL
to	NULL
stabilize	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
transcriptional	NULL
complex	NULL
that	NULL
mediates	NULL
induction	NULL
of	NULL
the	NULL
TNF-a	NULL
promoter	NULL
.	NULL

In	NULL
monocytic	NULL
cells	NULL
,	NULL
the	NULL
CRE	NULL
site	NULL
in	NULL
the	NULL
TNF-a	NULL
promoter	NULL
constitutively	NULL
bound	NULL
CREB	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Upon	NULL
LPS	NULL
stimulation	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
CREB	NULL
binding	NULL
remains	NULL
unchanged	NULL
,	NULL
but	NULL
there	NULL
was	NULL
a	NULL
marked	NULL
increase	NULL
in	NULL
c-Jun	NULL
binding	NULL
.	NULL

LPS	NULL
induces	NULL
c-jun	NULL
expression	NULL
(	NULL
23	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
increases	NULL
in	NULL
c-Jun-containing	NULL
complexes	NULL
observed	NULL
in	NULL
this	NULL
study	NULL
were	NULL
due	NULL
to	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
transactivating	NULL
activity	NULL
of	NULL
these	NULL
c-Jun	NULL
complexes	NULL
may	NULL
be	NULL
increased	NULL
due	NULL
to	NULL
post-translational	NULL
phosphorylation	NULL
(	NULL
24	NULL
)	NULL
.	NULL

As	NULL
reported	NULL
recently	NULL
,	NULL
LPS	NULL
stimulation	NULL
of	NULL
THP-1	NULL
cells	NULL
resulted	NULL
in	NULL
rapid	NULL
activation	NULL
of	NULL
JNK	NULL
(	NULL
25	NULL
)	NULL
.	NULL

The	NULL
phosphorylation	NULL
of	NULL
c-Jun	NULL
by	NULL
JNK	NULL
significantly	NULL
enhances	NULL
the	NULL
transactivation	NULL
potential	NULL
of	NULL
these	NULL
factors	NULL
(	NULL
26	NULL
)	NULL
.	NULL

The	NULL
non-consensus	NULL
CRE	NULL
sequence	NULL
of	NULL
TNF-a	NULL
promoter	NULL
TGAGCTCA	NULL
was	NULL
shown	NULL
to	NULL
have	NULL
a	NULL
lower	NULL
binding	NULL
affinity	NULL
for	NULL
c-Jun/ATF-2	NULL
complex	NULL
than	NULL
a	NULL
consensus	NULL
CRE	NULL
sequence	NULL
(	NULL
27	NULL
)	NULL
.	NULL

These	NULL
variations	NULL
of	NULL
sequences	NULL
and	NULL
the	NULL
resulting	NULL
variation	NULL
in	NULL
binding	NULL
of	NULL
these	NULL
bZIP	NULL
proteins	NULL
could	NULL
play	NULL
a	NULL
role	NULL
in	NULL
the	NULL
modulation	NULL
of	NULL
TNF-a	NULL
expression	NULL
in	NULL
response	NULL
to	NULL
various	NULL
signals	NULL
.	NULL

Importantly	NULL
,	NULL
base	NULL
substitution	NULL
in	NULL
the	NULL
CRE	NULL
site	NULL
that	NULL
reduced	NULL
CREB	NULL
binding	NULL
but	NULL
abolished	NULL
c-Jun	NULL
binding	NULL
abrogated	NULL
the	NULL
functional	NULL
activity	NULL
of	NULL
this	NULL
site	NULL
,	NULL
suggesting	NULL
that	NULL
c-Jun-containing	NULL
complexes	NULL
bound	NULL
to	NULL
region	NULL
II	NULL
are	NULL
required	NULL
for	NULL
LPS	NULL
induction	NULL
of	NULL
the	NULL
TNF-a	NULL
promoter	NULL
.	NULL

The	NULL
molecular	NULL
mechanisms	NULL
by	NULL
which	NULL
binding	NULL
of	NULL
the	NULL
nuclear	NULL
proteins	NULL
at	NULL
this	NULL
CRE	NULL
site	NULL
regulate	NULL
the	NULL
activation	NULL
of	NULL
TNF-a	NULL
gene	NULL
expression	NULL
await	NULL
further	NULL
elucidation	NULL
.	NULL

Parallel	NULL
to	NULL
our	NULL
findings	NULL
for	NULL
monocytic	NULL
cells	NULL
,	NULL
it	NULL
was	NULL
demonstrated	NULL
recently	NULL
that	NULL
both	NULL
the	NULL
«	NULL
B3	NULL
site	NULL
and	NULL
the	NULL
adjacent	NULL
upstream	NULL
CRE	NULL
site	NULL
are	NULL
required	NULL
for	NULL
the	NULL
calcium-stimulated	NULL
TNF-a	NULL
transcription	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
(	NULL
4	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
our	NULL
data	NULL
for	NULL
monocytes	NULL
,	NULL
these	NULL
investigators	NULL
reported	NULL
that	NULL
the	NULL
site	NULL
bound	NULL
NFATp	NULL
and	NULL
not	NULL
p50/p65	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
contrary	NULL
to	NULL
our	NULL
findings	NULL
in	NULL
monocytes	NULL
,	NULL
no	NULL
constitutive	NULL
or	NULL
induced	NULL
CREB	NULL
protein	NULL
binding	NULL
to	NULL
the	NULL
CRE	NULL
site	NULL
was	NULL
observed	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Instead	NULL
,	NULL
the	NULL
CRE-binding	NULL
complex	NULL
was	NULL
shown	NULL
to	NULL
consist	NULL
almost	NULL
exclusively	NULL
of	NULL
c-Jun/ATF-2	NULL
heterodimers	NULL
.	NULL

Furthermore	NULL
,	NULL
both	NULL
the	NULL
CRE	NULL
site	NULL
and	NULL
adjacent	NULL
upstream	NULL
Ets	NULL
site	NULL
were	NULL
essential	NULL
for	NULL
both	NULL
basal	NULL
promoter	NULL
activity	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
responsiveness	NULL
to	NULL
PMA	NULL
(	NULL
5	NULL
)	NULL
.	NULL

It	NULL
appears	NULL
that	NULL
the	NULL
Ets	NULL
site	NULL
did	NULL
not	NULL
play	NULL
a	NULL
significant	NULL
role	NULL
in	NULL
basal	NULL
TNF-a	NULL
promoter	NULL
activity	NULL
in	NULL
monocytes	NULL
,	NULL
since	NULL
it	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
mutation	NULL
of	NULL
the	NULL
Ets	NULL
*	NULL
J.	NULL
Yao	NULL
and	NULL
S.-T	NULL
.	NULL

Fan	NULL
,	NULL
submitted	NULL
for	NULL
publication	NULL
.	NULL

LPS	NULL
Induction	NULL
of	NULL
TNF-a	NULL
Promoter	NULL
in	NULL
Human	NULL
Monocytes	NULL
site	NULL
.	NULL
``	NULL

Together	NULL
,	NULL
these	NULL
results	NULL
demonstrate	NULL
the	NULL
marked	NULL
difference	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
TNF-a	NULL
promoter	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
and	NULL
monocytes	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
LPS	NULL
induction	NULL
of	NULL
a	NULL
heterologous	NULL
promoter	NULL
by	NULL
region	NULL
II	NULL
required	NULL
both	NULL
the	NULL
CRE	NULL
and	NULL
«	NULL
B3	NULL
sites	NULL
,	NULL
suggesting	NULL
a	NULL
functional	NULL
cooperation	NULL
between	NULL
the	NULL
transcription	NULL
factors	NULL
bound	NULL
to	NULL
these	NULL
sites	NULL
.	NULL

Similar	NULL
cooperation	NULL
has	NULL
also	NULL
been	NULL
demonstrated	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
another	NULL
cytokine	NULL
gene	NULL
,	NULL
IFN-	NULL
$	NULL
(	NULL
29	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
E-selectin	NULL
(	NULL
30	NULL
)	NULL
.	NULL

In	NULL
both	NULL
cases	NULL
,	NULL
ATF-2/Jun	NULL
proteins	NULL
were	NULL
shown	NULL
to	NULL
interact	NULL
with	NULL
p50/p65	NULL
proteins	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
p50/p65	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
physically	NULL
interact	NULL
with	NULL
ATF-2	NULL
(	NULL
29	NULL
)	NULL
,	NULL
and	NULL
c-Jun	NULL
(	NULL
31	NULL
)	NULL
.	NULL

These	NULL
direct	NULL
associations	NULL
are	NULL
considered	NULL
an	NULL
important	NULL
mechanism	NULL
by	NULL
which	NULL
transcriptional	NULL
factors	NULL
cooperate	NULL
to	NULL
induce	NULL
gene	NULL
expression	NULL
.	NULL

The	NULL
novel	NULL
findings	NULL
presented	NULL
here	NULL
support	NULL
the	NULL
notion	NULL
that	NULL
concerted	NULL
participation	NULL
of	NULL
proteins	NULL
bound	NULL
to	NULL
the	NULL
Egr-1	NULL
,	NULL
CRE	NULL
,	NULL
and	NULL
«	NULL
B3	NULL
sites	NULL
mediates	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
TNF-a	NULL
promoter	NULL
in	NULL
human	NULL
monocytic	NULL
THP-1	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
.	NULL

Future	NULL
studies	NULL
will	NULL
determine	NULL
if	NULL
similar	NULL
regulatory	NULL
pathways	NULL
control	NULL
TNF-a	NULL
gene	NULL
expression	NULL
in	NULL
monocytes	NULL
and	NULL
macrophages	NULL
.	NULL

Further	NULL
elucidation	NULL
of	NULL
the	NULL
cooperative	NULL
interactions	NULL
of	NULL
transcription	NULL
factors	NULL
bound	NULL
to	NULL
these	NULL
cis-acting	NULL
regulatory	NULL
elements	NULL
are	NULL
essential	NULL
to	NULL
our	NULL
understanding	NULL
of	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
TNF-a	NULL
gene	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

Understanding	NULL
of	NULL
the	NULL
molecular	NULL
mechanisms	NULL
by	NULL
which	NULL
these	NULL
nuclear	NULL
factors	NULL
regulate	NULL
TNF-a	NULL
gene	NULL
expression	NULL
should	NULL
lead	NULL
to	NULL
design	NULL
of	NULL
specific	NULL
inhib-itors	NULL
that	NULL
will	NULL
counteract	NULL
the	NULL
pathological	NULL
effects	NULL
of	NULL
TNF-a	NULL
in	NULL
various	NULL
diseases	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
Dr.	NULL
James	NULL
S.	NULL
Economou	NULL
for	NULL
the	NULL
generous	NULL
gift	NULL
of	NULL
plasmids	NULL
,	NULL
and	NULL
Dr.	NULL
Craig	NULL
Dickinson	NULL
and	NULL
Paul	NULL
Oeth	NULL
for	NULL
advice	NULL
.	NULL

REFERENCES	NULL
.	NULL

Tracey	NULL
,	NULL
K.	NULL
J.	NULL
,	NULL
and	NULL
Cerami	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Med	NULL
.	NULL

45	NULL
,	NULL
491-503	NULL
.	NULL

Han	NULL
,	NULL
J.	NULL
,	NULL
Brown	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Beutler	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

171	NULL
,	NULL
465-475	NULL
.	NULL

Han	NULL
,	NULL
J.	NULL
,	NULL
Huez	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Beutler	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

146	NULL
,	NULL
1848-1848	NULL
.	NULL

Tsai	NULL
,	NULL
E.	NULL
Y.	NULL
,	NULL
Jain	NULL
,	NULL
J.	NULL
,	NULL
Pesavento	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Rao	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Goldfeld	NULL
,	NULL
A	NULL
.	NULL

E.	NULL
(	NULL
1996	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16	NULL
,	NULL
459-467	NULL
.	NULL

Kramer	NULL
,	NULL
B.	NULL
,	NULL
Weigmann	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Kronke	NULL
,	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
6577-6583	NULL
6	NULL
.	NULL

Rhoades	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
Golub	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
and	NULL
Economou	NULL
,	NULL
J.	NULL
S.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
22102-22107	NULL
7	NULL
.	NULL

Kramer	NULL
,	NULL
B.	NULL
,	NULL
Meichle	NULL
,	NULL
A.	NULL
,	NULL
Hensel	NULL
,	NULL
G.	NULL
,	NULL
Charnay	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Kronke	NULL
,	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1219	NULL
,	NULL
418-421	NULL
8	NULL
.	NULL

Leitman	NULL
,	NULL
D.	NULL
C.	NULL
,	NULL
Ribeiro	NULL
,	NULL
R.	NULL
C.	NULL
J.	NULL
,	NULL
Mackow	NULL
,	NULL
E.	NULL
R.	NULL
,	NULL
Baxter	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
and	NULL
West	NULL
,	NULL
B.	NULL
L.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
9843-9346	NULL
9	NULL
.	NULL

Pope	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
Leutz	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Ness	NULL
,	NULL
S.	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

94	NULL
,	NULL
1449-1455	NULL
.	NULL

10	NULL
.	NULL

Rhoades	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
Cai	NULL
,	NULL
S.	NULL
,	NULL
Golub	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
and	NULL
Economou	NULL
,	NULL
J.	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
Cell	NULL
.	NULL

Immunol	NULL
.	NULL

161	NULL
,	NULL
125-131	NULL
11	NULL
.	NULL

Trede	NULL
,	NULL
N.	NULL
S.	NULL
,	NULL
Tsytsykova	NULL
,	NULL
A.	NULL
V.	NULL
,	NULL
Chatila	NULL
,	NULL
T.	NULL
,	NULL
Goldfeld	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
and	NULL
Geha	NULL
,	NULL
R.	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

155	NULL
,	NULL
902-908	NULL
12	NULL
.	NULL

Leitman	NULL
,	NULL
D.	NULL
C.	NULL
,	NULL
Mackow	NULL
,	NULL
E.	NULL
R.	NULL
,	NULL
Williams	NULL
,	NULL
T.	NULL
,	NULL
Baxter	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
and	NULL
West	NULL
,	NULL
B.	NULL
L.	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
1352-1356	NULL
13	NULL
.	NULL

Shakhov	NULL
,	NULL
A.	NULL
N.	NULL
,	NULL
Collat	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Vassalli	NULL
,	NULL
P.	NULL
,	NULL
Nedospasov	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
and	NULL
Jongeneel	NULL
,	NULL
V.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

171	NULL
,	NULL
35-47	NULL
14	NULL
.	NULL

Collart	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Baeuerle	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Vassalli	NULL
,	NULL
P.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
1498-1506	NULL
15	NULL
.	NULL

Goldfeld	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
Doyle	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Naf	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

87	NULL
,	NULL
9769-9778	NULL
16	NULL
.	NULL

Ziegler-Heitbrock	NULL
,	NULL
L.	NULL
H.	NULL
W.	NULL
,	NULL
Sternsdorf	NULL
,	NULL
T.	NULL
,	NULL
Liese	NULL
,	NULL
J.	NULL
,	NULL
Belohradsky	NULL
,	NULL
B.	NULL
,	NULL
Weber	NULL
,	NULL
C.	NULL
,	NULL
Wedel	NULL
,	NULL
A.	NULL
,	NULL
Schreck	NULL
,	NULL
R.	NULL
,	NULL
Bauerle	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Strobel	NULL
,	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

151	NULL
,	NULL
6986-6993	NULL
17	NULL
.	NULL

Oeth	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Mackman	NULL
,	NULL
N.	NULL
(	NULL
1995	NULL
)	NULL
Blood	NULL
86	NULL
,	NULL
4144-4152	NULL
18	NULL
.	NULL

Fan	NULL
,	NULL
S.-T.	NULL
,	NULL
Mackman	NULL
,	NULL
N.	NULL
,	NULL
Cui	NULL
,	NULL
M.-J	NULL
.	NULL

,	NULL
and	NULL
Edgington	NULL
,	NULL
T.	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

154	NULL
,	NULL
3266-3274	NULL
19	NULL
.	NULL

Economou	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Rhoades	NULL
,	NULL
K.	NULL
,	NULL
Essner	NULL
,	NULL
R.	NULL
,	NULL
McBride	NULL
,	NULL
W.	NULL
H.	NULL
,	NULL
Gasson	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
and	NULL
Morton	NULL
,	NULL
D.	NULL
L.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

170	NULL
,	NULL
821-826	NULL
20	NULL
.	NULL

Mackman	NULL
,	NULL
N.	NULL
,	NULL
Brand	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Edgington	NULL
,	NULL
T.	NULL
S.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

174	NULL
,	NULL
1517-1526	NULL
21	NULL
.	NULL

Coleman	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
Bartiss	NULL
,	NULL
A.	NULL
H.	NULL
,	NULL
Sukhatme	NULL
,	NULL
V.	NULL
P.	NULL
,	NULL
Liu	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Rupprecht	NULL
,	NULL
H.	NULL
D.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

149	NULL
,	NULL
3045-3051	NULL
22	NULL
.	NULL

Cui	NULL
,	NULL
M.-Z	NULL
.	NULL

,	NULL
Parry	NULL
,	NULL
G.	NULL
C.	NULL
N.	NULL
,	NULL
Octh	NULL
,	NULL
P.	NULL
,	NULL
Larson	NULL
,	NULL
H.	NULL
,	NULL
Smith	NULL
,	NULL
M.	NULL
,	NULL
Huang	NULL
,	NULL
R.-P.	NULL
,	NULL
Adamson	NULL
,	NULL
E.	NULL
D.	NULL
,	NULL
and	NULL
Mackman	NULL
,	NULL
N.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
,	NULL
2731-2789	NULL
28	NULL
.	NULL

Dokter	NULL
,	NULL
W.	NULL
H.	NULL
A.	NULL
,	NULL
Esselink	NULL
,	NULL
M.	NULL
T.	NULL
,	NULL
Halie	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
Vellenga	NULL
,	NULL
E.	NULL
(	NULL
1993	NULL
)	NULL
Blood	NULL
81	NULL
,	NULL
337-343	NULL
24	NULL
.	NULL

Karin	NULL
,	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
16488-16486	NULL
25	NULL
.	NULL

Hambleton	NULL
,	NULL
J.	NULL
,	NULL
Weinstein	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Lem	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
DeFranco	NULL
,	NULL
A.	NULL
L.	NULL
(	NULL
1996	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

98	NULL
,	NULL
2774-2778	NULL
26	NULL
.	NULL

Smeal	NULL
,	NULL
T.	NULL
,	NULL
Binetruy	NULL
,	NULL
B.	NULL
,	NULL
Mercola	NULL
,	NULL
D.	NULL
,	NULL
Grover-Bardwick	NULL
,	NULL
E.	NULL
,	NULL
Heidecker	NULL
,	NULL
G.	NULL
,	NULL
Rapp	NULL
,	NULL
U.	NULL
R.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
3507-3513	NULL
im	NULL
Co	NULL
bo	NULL
is	NULL
gr	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
LPS	NULL
Induction	NULL
of	NULL
TNF-a	NULL
Promoter	NULL
in	NULL
Human	NULL
Monocytes	NULL
17801	NULL
27	NULL
.	NULL

Newell	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
Deisseroth	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
,	NULL
and	NULL
Lopez-Berestein	NULL
,	NULL
G.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Leukocyte	NULL
Biol	NULL
.	NULL

56	NULL
,	NULL
27-85	NULL
28	NULL
.	NULL

McCaffrey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
Goldfeld	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
and	NULL
Rao	NULL
,	NULL
A	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
30445-30450	NULL
29	NULL
.	NULL

Du	NULL
,	NULL
W.	NULL
,	NULL
Thanos	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1998	NULL
)	NULL
Cell	NULL
74	NULL
,	NULL
887-898	NULL
30	NULL
.	NULL

Whitley	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Thanos	NULL
,	NULL
D.	NULL
,	NULL
Read	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Maniatis	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Collins	NULL
,	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
6464-6475	NULL
31	NULL
.	NULL

Kaszubska	NULL
,	NULL
W.	NULL
,	NULL
Hoof	NULL
van	NULL
Huijsduijnen	NULL
,	NULL
R.	NULL
,	NULL
Ghersa	NULL
,	NULL
P.	NULL
,	NULL
DeRaemy-Schenk	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Chen	NULL
,	NULL
B.	NULL
P.	NULL
C.	NULL
,	NULL
Hei	NULL
,	NULL
T.	NULL
,	NULL
DeLamarter	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
and	NULL
Whelan	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
7180-7190	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
Lipopolysaccharide	NULL
Induction	NULL
of	NULL
the	NULL
Tumor	NULL
Necrosis	NULL
Factor-	NULL
(	NULL
Promoter	NULL
in	NULL
Human	NULL
Monocytic	NULL
Cells	NULL
:	NULL
REGULATION	NULL
BY	NULL
Egr-1	NULL
,	NULL
c-Jun	NULL
,	NULL
AND	NULL
NF-	NULL
xB	NULL
TRANSCRIPTION	NULL
FACTORS	NULL
Jin	NULL
Yao	NULL
,	NULL
Nigel	NULL
Mackman	NULL
,	NULL
Thomas	NULL
S.	NULL
Edgington	NULL
and	NULL
Sao-Tah	NULL
Fan	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1997	NULL
,	NULL
272:17795-17801.	NULL
doi	NULL
:	NULL
10.1074/jb0.272.28.17795	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
7795	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
31	NULL
references	NULL
,	NULL
25	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
7795.	NULL
full.html	NULL
#	NULL
ref-list-1	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL

